This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
HBSP (USA)
-
Health Catalyst
Schulman, Kevin A; Balu, SureshCase HBS-316098-EDan Burton, Health Catalyst CEO (HBS Baker Scholar), and Tom Burton, Health Catalyst Senior Vice President of Product Development and co-founder closed on a $41 million investment round. Their firm was one of the hottest companies in the health information technology field. They provided core data warehouse technology to enable analytics from electronic health record systems. Still, they faced significant competition in this space. Could they exe...Starting at €8.20
-
Product Portfolio Management at Genentech
Schulman, Kevin A; Gresh, JamieCase HBS-317012-EFinanceGenentech, long the darling of the biotechnology industry, was acquired by Swiss pharmaceutical company Roche in 2009. The combined company retains the name Genentech in the US, but must now move to achieve the promises made at the time of this merger-to build from made Genentech great. One of the key tasks for Genentech CEO Ian Clark and CFO Ashraf Hanna was to implement a new portfolio management process for the combined entity. This case explo...Starting at €8.20
-
Shisong Cardiac Center: Kumbo, Cameroon
Schulman, Kevin A; Konthcou, Nelly-AngeCase HBS-317085-EShisong Cardiac Center in Kumbo, Cameroon, is a regional cardiac referral center in central Africa. As the continent transitions from communicable to non-communicable diseases, there is a critical shortage of surgical care required to treat these conditions. This case describes an innovation solution to the shortage of professional skills, an international collaboration between a hospital in Milan and a hospital in Cameroon. The case highlights t...Starting at €8.20
-
PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World
Schulman, Kevin A; Moodley, Sashidaran; Vasudevan, AnantCase HBS-317103-EEntrepreneurshipPharmAccess is an Amsterdam based NGO working to support the development of the private health care market in Africa. This work is critical as over 50% of care is delivered through the private sector, but well-intentioned efforts to address global health through the public sector have the unintended consequence of crowding-out capital formation in the private sector. PharmaAccess is working to crowd-in funding instead through the development of a...Starting at €8.20
-
Obesity Management at Kaiser Permanente: A New Mindset for Healthcare Delivery
Schulman, Kevin A; Leya, Gregory; Beveridge, ChristianaCase HBS-317106-EStrategyKaiser Permanente (KP) is the largest managed care organization in the US with over 10 million members. KP evolved from a pre-payment or capitation model that focuses the organization around the efficiency of care and the health of the population it serves. This financial model is in stark contrast to the fee-for-service payment model for other health care organizations. Given the epidemic of obesity in the US, KP is facing an enormous potential ...Starting at €8.20
-
MedCath Corporation (C)
Herzlinger, Regina E.; Schulman, Kevin A; Upke, F. FallonCase HBS-315018-EMedCath is a horizontally integrated chain of heart hospitals that partners with local cardiologists. It claims that its focus leads to better and cheaper results than those of an everything-for-everybody general hospital. Community hospitals generally vehemently oppose their entry into a new area. What options does MedCath have?Starting at €5.74
-
Aggressive Growth Plans For Zimmer Spine
Schulman, Kevin A; Shaw, MirandaCase HBS-316106-ESteve Healy, the President of Zimmer Spine, has to transform his organization into a market leader. Zimmer is a major medical device firm, but the Spine division has underperformed and it's core technology did not get the expanded FDA label that had been expected. The case reviews the industry, the competitive landscape, and the potential growth strategies for Zimmer Spine to consider.Starting at €8.20
-
Nutrition Science Initiative: Are All Calories Created Equal
Schulman, Kevin A; Dabora, MatanCase HBS-317033-EOn 2012, Gary Taubes lunched the Nutrition Science initiative (NuSI), a not for profit organization aiming to question the mainstream scientific paradigm regarding obesity and dietary recommendations. This case provides a brief scientific background on obesity and its causes, comorbidities and the economic cost of this epidemic. It then discusses the two main hypotheses of diet, and the formation of NuSI. Finally, it describes the unique challeng...Starting at €8.20
-
From mHealth Hackathon to Reality: Diabetes Care
Schulman, Kevin A; Cheek, CurryCase HBS-317105-EStrategyThis case explores the development of a business plan for a mobile health application for diabetes care. The case depicts a student team excited about the opportunity to improve the care of patients with diabetes by contracting an app. They go through a rigorous evaluation of the FDA regulations, the existing market, and potential commercial competitors to try and identify a market opportunity. Since diabetes care involves behavior change, the c...Starting at €8.20
-
AbbVie
Schulman, Kevin A; Little, Laura; Mullangi, Samyukta; Schleicher, StephenCase HBS-316095-EThis case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds it's largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars market entrants, and a series of adverse financial forecasts for AbbVie. Given all of these risks, did the acquisition add value to shareholders? AbbVie made headlines in March 2015 wh...Starting at €8.20